Focus on the development and commercialization of new drugs for perioperative anesthesia, analgesia and anti-inflammation.

Cali Biosciences

We are an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have several patented technology platforms and an international team of scientific research and management talents. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia and anti-inflammatory. In the future, we will also promote the commercialization of products to fully respond to the unmet market demand.

More

R&D PipelineCali Biosciences has built a pipeline of products including multiple drug candidates.

More

Technology platformCali Biosciences possesses multiple patented drug delivery technology platforms.

More

R&D CenterThe drug R&D center of Cali Biosciences focuses on the research of complex formulations of perioperative drugs.

More

News

Cali Biosciences Announces Publication of Successful Phase 2 S...

SAN DIEGO, May 20, 2024 -- Cali Biosciences Co., Ltd. (hereinafter referred to as “Cali Biosciences”), a biotechnology company de...

Cali Biosciences Initiates Second Phase III Study of CPL-...

Subjects in Bunionectomy Study Dosed  Data Presented at American Society for Pharmacology and Experimental Therapeutics Shows Simila...

Cali Biosciences Initiates Phase III Studies of CPL-01 (L...

- Subjects in Herniorrhaphy Study Dosed - Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed SA...